GABA and GLP-1 Receptor Agonist Combination Therapy Modifies Diabetes and Langerhans Islet Cytoarchitecture in a Rat Model of Wolfram Syndrome

Five-month-old glucose intolerant Wolfram syndrome rats and their wild-type littermates were daily treated with GABA, liraglutide, or a combination of both.